Transcribed explores the human stories behind biotech breakthroughs. Benchling CEO Sajith Wickramasekara sits down with scientists, founders, and R&D leaders to talk candidly about the decisions shaping modern biotech. From career pivots to breakthroughs, setbacks, and lessons in leadership, these are real conversations with the people moving science forward.
All content for Transcribed is the property of Benchling and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Transcribed explores the human stories behind biotech breakthroughs. Benchling CEO Sajith Wickramasekara sits down with scientists, founders, and R&D leaders to talk candidly about the decisions shaping modern biotech. From career pivots to breakthroughs, setbacks, and lessons in leadership, these are real conversations with the people moving science forward.
Andrew Bellinger discusses what it takes to build new drug modalities from scratch, the bold bets and tough calls that shaped Verve’s journey, and lessons in building new companies from first-in-class science.
Karen Akinsanya unpacks on the rise of computational drug discovery, what it takes to prove impact of new technologies, and the importance of setting realistic expectations for AI.
Transcribed explores the human stories behind biotech breakthroughs. Benchling CEO Sajith Wickramasekara sits down with scientists, founders, and R&D leaders to talk candidly about the decisions shaping modern biotech. From career pivots to breakthroughs, setbacks, and lessons in leadership, these are real conversations with the people moving science forward.
